Stakeholders task firms on patent right for HIV, hepatitis C drugs

    Published By:

    In order to provide low- and middle-income countries with access to life-saving medications, stakeholders have asked for an open license for the generic production of HIV and hepatitis C medications.

    The decision was made by the participants during a press conference held on Tuesday in Abuja by the AIDS HealthCare Foundation.

    The Country Program Director, AHF Nigeria Dr Echey Ijezie,  called on Gilead, a pharmaceutical company based in the United States to stop evergreening patents on HIV and AIDS drugs like Truvada.

    The Country Program Director said the company had priced several of its HIV and hepatitis C drugs out of reach for many people, by refusing to register some drugs in developing countries.

    Ijezie said, “Gilead should open the license for the generic production of the hepatitis C drug to allow middle and low-income countries to have access without exception. They should license the technology for the production of treatment for cryptococcal meningitis to generic manufacturers among others.”

    Director for Advocacy and Marketing for Africa Breau AHF, Ms Oluwkemi Gbadamosi, said Gilead should be held accountable for placing a price on the most effective, modern, and lifesaving medicines.

    “The research and development are often funded by U.S. taxpayers, but for their generosity, the public is rewarded with astronomical drug prices. For example, a highly effective hepatitis C drug cost $1,000 per pill and a 12-week course of treatment has a retail price of over $90,000 in the U.S.

    “A generic version of the same drug cost only $4 per pill in India, but according to Medecins Sans Frontieres, Gilead has excluded 50 middle-income countries from access to the generic discounted price. These excluded countries like Jamaica, Tunisia, the Philippines, Ukraine, and Venezuela among others.

    She said, “Gilead holds a patent on the technology needed to produce the drug; therefore generic manufacturers cannot produce it at a lower cost. Gilead has promised but failed to deliver on a commitment to provide the drug to 116 countries at $16 per vial and has not even registered the drugs in these countries, but relying on local suppliers.

    Gilead has generated billions of dollars in profit by maintaining a monopoly on some of the most effective and well-tolerated antiretroviral drugs. In 2016 when the estimated cost of Atripla in the developing world was around $100 per patient per year, the U.S. government paid $30,000 per patient, per year for the same drug.”

    Also speaking, the Executive Secretary of Nigeria Network of  Religious Leaders Living with HIV/AIDS, Ms Amber Erinunwinhe, said the lives of people must matter first before profiteering.

    She said, “We must look at the lives of people, the people you are producing these drugs for should be the number one before your profit. This is because if the lives are not there tomorrow, I don’t think they would make a such profit, and am happy the advocacy is not just Nigeria but a global one.”

    Queen Ferry
    Queen Ferry
    Chinyere Treasure Ikechukwu known professionally as Queen Ferry, is a Nigerian business Executive, Journalist and Content Editor. She serves as the Vice-Chairman of Naijatraffic Limited and also the CEO of Wakadaily. If Treasure is not blogging, she will be making delicious delicacy.

    Most Popular Read

    Sunshine Rosman Biography: Age, Education, Career, Movies

    Sunshine Rosman (born on July 25)is a Nigerian actress, filmmaker, Model, host, and media influencer. She became prominent for her role as Amara in the...

    Margarida Corceiro Biography: Age, Education, Career

    Margarida Corceiro (born October 26, 2002) generally addressed as Magui Corceiro is a Portuguese actress, model, and media influencer. She rose to fame after her...

    Queen Kalisha Biography: Age, Education, Career

    Queendarline Onyinyechi Okoh (born 14th April 1996) Better addressed as Queen Kalisha is a Nigerian Fast rising Model, social media influencer, entrepreneur, and philanthropist. She is...

    ASUU loses again as Court order lecturer to resume work immediately

    The Court of Appeal sitting in Abuja has ordered the Academic Staff Union of Universities (ASUU) to call off its ongoing strike action with...

    Yul Edochie Biography

    Yul Chibuike Daniel Edochie (born January 7, 1982), professionally as Yul Edochie, is a gifted Nigerian actor, businessman, and politician. He is named after the famous...

    Harry B Biography: Age, Education, Career, Movies

    Harry B Anyanwu (born on October 9th, 1959) professionally known as Harry B is a veteran Nigerian actor, musical Rapper, and entertainer. He originated hails...

    Different Shades of Grace

    Grace is a word we use to describe God's free gifts. It comes in different shades: 1. Talent: Talent can't be learned, it can be...

    Four burnt to death, 16 injured in Lagos-Ibadan Expressway accident 

    No fewer than four persons were reportedly burnt to death while sixth others sustained several injuries in a lone accident on Lagos-Ibadan Expressway on...

    Orion Acaba Biography: Age, Education, Career

    Orion Acaba (born 14, October 1980) is a famous  American voice actor. He became prominent for his work of Tiberius Stormwind in the first campaign...

    My Sound will Redefine Afrobeat – Sam Dloverboy

    Fast-rising Afrobeat artist, Rotimi Samuel Oluwasogo who is professionally known as Sam Dloverboy has said that his music will redefine Afrobeat sound. Sam Dloverboy made...